Literature DB >> 2109579

Tolerance and efficacy of parenterally administered penicillin-streptomycin and orally administered amoxicillin or penicillin V for prophylaxis of experimentally induced streptococcal endocarditis.

R Pujadas1, E Escriva, J Jane, J Argimon, F Fernandez, P Fava, M Galera, J Garau.   

Abstract

A regimen of a single intramuscular dose of penicillin G-streptomycin was compared with regimens of three oral doses of amoxicillin and two oral doses of penicillin V to prevent Streptococcus sanguis endocarditis in rabbits with experimentally induced valvular heart lesions. Challenge doses of 10(4), 10(6), and 10(8) CFU of a strain of S. sanguis highly tolerant to penicillin and amoxicillin were used. The combination of penicillin and streptomycin was the only regimen tested that provided full protection even against the highest inoculum concentration. A single oral dose of penicillin V (36 mg/kg) or amoxicillin (50 mg/kg), two oral doses of penicillin V (36 and 18 mg/kg with a 7-h interval between doses), or six oral doses of amoxicillin (50 mg/kg followed by 8.5 mg/kg at 8-h intervals) protected recipients of the lowest inoculum concentration; protection diminished with increasing inocula. In contrast, administration of two high oral doses of amoxicillin (50 mg/kg) with a 10-h interval between doses provided full protection against challenge doses of 10(4) and 10(6) CFU, preventing endocarditis in 10 (66%) of 15 recipients of 10(8) CFU. All regimens evaluated were highly effective in preventing endocarditis when rabbits were challenged with 10(4) CFU. The combination of penicillin and streptomycin was the best regimen tested. Administration of two high oral doses of amoxicillin (50 mg/kg) with a 10-h interval between doses led to significantly fewer infections when compared with the other oral regimens when rabbits were challenged with 10(6) and 10(8) CFU.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2109579      PMCID: PMC171580          DOI: 10.1128/AAC.34.2.321

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Amoxycillin compared with penicillin V for the prophylaxis of dental bacteraemia.

Authors:  D C Shanson; P Cannon; M Wilks
Journal:  J Antimicrob Chemother       Date:  1978-09       Impact factor: 5.790

2.  Penicillin tolerance in experimental streptococcal endocarditis.

Authors:  L Pulliam; S Inokuchi; W K Hadley; J Mills
Journal:  Lancet       Date:  1979-11-03       Impact factor: 79.321

3.  Chemotherapy of experimental streptococcal endocarditis. I. Comparison of commonly recommended prophylactic regimens.

Authors:  D T Durack; R G Petersdorf
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

4.  Penicillin tolerance and bacterial endocarditis.

Authors:  Y Holloway; J Dankert; J Hess
Journal:  Lancet       Date:  1980-03-15       Impact factor: 79.321

5.  Chemotherapy of experimental streptococcal endocarditis. IV. Further observations on prophylaxis.

Authors:  L L Pelletier; D T Durack; R G Petersdorf
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

6.  Penicillin-sensitive streptococcal endocarditis. In-vitro and clinical observations on penicillin-streptomycin therapy.

Authors:  J C Wolfe; W D Johnson
Journal:  Ann Intern Med       Date:  1974-08       Impact factor: 25.391

7.  Vancomycin prophylaxis of experimental Streptococcus sanguis. Inhibition of bacterial adherence rather than bacterial killing.

Authors:  J P Bernard; P Francioli; M P Glauser
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

8.  Lethal effect of a heterologous murein hydrolase on penicillin-treated Streptococcus sanguis.

Authors:  D Horne; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

9.  Efficacy of orally administered penicillin V for prophylaxis of experimentally induced streptococcal endocarditis.

Authors:  R Pujadas; E Escriva; J Jane; M C Galera; P Fava; J Garau; B Mirelis
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

10.  Experimental endocarditis. II. Staphylococcal infection of the aortic valve following placement of a polyethylene catheter in the left side of the heart.

Authors:  B B Perlman; L R Freedman
Journal:  Yale J Biol Med       Date:  1971-10
View more
  2 in total

1.  Successful single-dose teicoplanin prophylaxis against experimental streptococcal, enterococcal, and staphylococcal aortic valve endocarditis.

Authors:  G S Perdikaris; A Pefanis; H Giamarellou; A Nikolopoulos; E P Margaris; I Donta; A Tsitsika; P Karayiannakos
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

2.  Role of tolerance in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis with vancomycin, teicoplanin, and daptomycin.

Authors:  G P Voorn; J Kuyvenhoven; W H Goessens; W C Schmal-Bauer; P H Broeders; J Thompson; M F Michel
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.